O
Organogenesis Holdings Inc.
ORGO · NASDAQ · Healthcare · 230M
Closing price
$1.29
+0.78% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
4.4×
Price / net assetsP/B
0.4×
Enterprise value / EBITDAEV/EBITDA
2.7×
Free cash flow yieldFCF yield
-15.0%
Return on equityROE
8.5%
Operating margin
9.9%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.